This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Takeda Pharmaceutical Company Limited, Other. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Toyonaka, JP (2010)
- 1-chome, Toyonaka-shi, Osaka, JP (2010)
Company Filing History:

Years Active: 2010
Title: Iichirou Shimomura: Innovator in Protein Research
Introduction
Iichirou Shimomura is a notable inventor based in Toyonaka-shi, Osaka, Japan. He has made significant contributions to the field of protein research, particularly in the areas of adipocyte differentiation and skeletal muscle function. With a total of 2 patents, his work has implications for therapeutic and diagnostic applications.
Latest Patents
Shimomura's latest patents include innovative methods and proteins that address critical health issues. One of his patents focuses on a method of suppressing the differentiation of an adipocyte and lipid accumulation. This method involves contacting the adipocyte with a specific protein or polynucleotide. His other patent introduces a novel secretory or membrane protein expressed in skeletal muscles. This invention is aimed at providing a prophylactic or therapeutic agent for diseases associated with skeletal muscle abnormalities.
Career Highlights
Throughout his career, Iichirou Shimomura has worked with prominent organizations, including Takeda Pharmaceutical Company Limited. His research has contributed to advancements in understanding protein functions and their applications in medicine.
Collaborations
Shimomura has collaborated with notable colleagues such as Yuji Matsuzawa and Tohru Funahashi. These partnerships have enhanced his research and innovation efforts.
Conclusion
Iichirou Shimomura's work in protein research exemplifies the impact of innovation in addressing health challenges. His patents and collaborations continue to influence the scientific community and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile